Multiple Manufacturers

ARIXTRA

Manufacturer:

Multiple Manufacturers

Arixtra HCPCS:

J1652

HCPCS Code Descriptor:

Injection, fondaparinux sodium, 0.5 mg

Category:

J Code

Arixtra NDCs:

67457-0593-04, 67457-0595-08, 67457-0594-06, 67457-0585-08, 67457-0584-06, 67457-0583-04, 55150-0233-10, 55150-0231-10, 55150-0232-10, 67457-0592-10, 70710-1515-06, 55111-0681-10, 55111-0680-10, 00781-3476-95, 55111-0679-10, 00781-3454-95, 00781-3465-95, 43598-0606-10, 43598-0608-10, 43598-0609-10, 67457-0582-10, 55150-0230-10, 70710-1514-06, 00781-3443-95, 55111-0678-10, 00781-3476-12, 00781-3454-12, 00781-3465-12, 43598-0607-10, 55111-0681-02, 55111-0680-02, 55111-0679-02, 70710-1514-09, 00781-3443-12, 43598-0608-02, 43598-0606-02, 43598-0609-02, 55111-0678-02, 43598-0607-02

Primary Type:

Anti-coagulant

Generic/Specialty Status:

Multi-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Arixtra:

ARIXTRA is an Anti-coagulant drug manufactured by Mylan and administered via the Subcutaneous route of administration. The J Code: J1652 is aligned to the drug ARIXTRA.

ACCESS PRICING AND MORE BY REGISTERING

J1652 Added Date:

January 1, 2003

J1652 Effective Date:

January 1, 2003

J1652 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Arixtra billing and coding information.
Arixtra patient assistance information can be found through Viatris Patient Assistance Program at the URL: https://www.viatris.com/en-us/lm/united-states/patient-assistance-program
ARIXTRA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ARIXTRA. Please check back in a few weeks.